FindMyKOL
Clinical trialNCT02333955WithdrawnPhase 2Interventional

A Phase 2 Extension of Study GCS-100-CS-4003

SponsorLa Jolla Pharmaceutical CompanyEnrollment0Chronic Kidney Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of this study is to determine the safety and tolerability of extended dosing with a fixed dose of GCS-100 3 mg IV push in patients with Chronic Kidney Disease (CKD).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Southwest Clinical Research Institute, Llc

    Tempe, Arizona, United States

  • California Institute of Renal Research

    La Mesa, California, United States

  • Denver Nephrology

    Denver, Colorado, United States

  • Mountain Kidney and Hypertension Associates, Pa

    Asheville, North Carolina, United States

  • Clinical Advancement Center, Pllc

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GCS-100
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2015
Primary completion
31 Jul 2016
Completion
31 Jul 2016
Last update posted
15 Jan 2015
Registered enrollment
0
Registry id
NCT02333955
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.